Insider Transactions in Q2 2022 at Bridge Bio Pharma, Inc. (BBIO)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 16
2022
|
Charles J Homcy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,541
-0.13%
|
$9,246
$6.74 P/Share
|
|
May 16
2022
|
Charles J Homcy |
BUY
Exercise of conversion of derivative security
|
Direct |
3,759
+0.31%
|
-
|
|
May 16
2022
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,228
-2.77%
|
$55,368
$6.74 P/Share
|
|
May 16
2022
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,680
+7.42%
|
-
|
|
May 16
2022
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,759
-0.5%
|
$142,554
$6.74 P/Share
|
|
May 16
2022
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,705
+1.41%
|
-
|
|
May 16
2022
|
Richard H Scheller Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,310
-2.67%
|
$7,860
$6.74 P/Share
|
|
May 16
2022
|
Richard H Scheller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,195
+6.11%
|
-
|